Welcome to Dwaey, specifically on Deflazacort page.
This medicine contains important and useful components, as it consists of
Deflazacort is available in the market in concentration.
Deflazacort
- Monitor Blood Sugar Levels: Deflazacort can increase blood sugar levels, especially in patients with diabetes. Regular monitoring and adjustments in diabetes medication may be required.
- Infections: This drug can suppress the immune system, making you more susceptible to infections. Avoid contact with people who have contagious illnesses.
- Bone Health: Long-term use can lead to osteoporosis. Consider calcium and vitamin D supplements, and monitor bone density regularly.
- Eye Health: Regular eye check-ups are necessary as Deflazacort can cause cataracts or glaucoma.
- Vaccinations: Live vaccines should be avoided while on this medication. Consult your doctor before any vaccinations.
- Mental Health: This drug can cause mood swings, anxiety, or depression. Inform your healthcare provider if you experience any mental health changes.
- Gastrointestinal Issues: Risk of ulcers or gastrointestinal bleeding increases. Use with caution if you have a history of stomach issues.
- Inflammatory Conditions: Deflazacort is primarily used to treat inflammatory conditions such as rheumatoid arthritis, lupus, and psoriasis.
- Allergic Reactions: It is effective in managing severe allergic reactions, including asthma and dermatitis.
- Autoimmune Disorders: Used in conditions like multiple sclerosis and myasthenia gravis to suppress the immune response.
- Organ Transplants: Helps prevent organ rejection by suppressing the immune system.
- Respiratory Conditions: Used in chronic obstructive pulmonary disease (COPD) and severe asthma to reduce inflammation.
- Skin Disorders: Effective in treating severe eczema and other inflammatory skin conditions.
- Hematologic Conditions: Used in the management of certain blood disorders like idiopathic thrombocytopenic purpura (ITP).
- Systemic Infections: Avoid use in patients with untreated systemic infections due to the risk of worsening the infection.
- Hypersensitivity: Do not use if there is a known hypersensitivity to Deflazacort or any of its components.
- Live Vaccines: Contraindicated in patients receiving live vaccines due to the risk of vaccine-induced infections.
- Peptic Ulcer Disease: Use with caution in patients with active peptic ulcers or a history of gastrointestinal bleeding.
- Osteoporosis: Avoid long-term use in patients with severe osteoporosis unless absolutely necessary.
- Psychiatric Disorders: Contraindicated in patients with severe psychiatric disorders due to the risk of exacerbation.
- Cardiac Issues: Use with caution in patients with congestive heart failure or hypertension.
- Gastrointestinal Issues: Nausea, vomiting, and stomach ulcers are common.
- Endocrine Effects: Can cause Cushing's syndrome, weight gain, and hyperglycemia.
- Musculoskeletal: Long-term use can lead to muscle weakness and osteoporosis.
- Ophthalmic: Increased risk of cataracts and glaucoma.
- Cardiovascular: May cause hypertension and fluid retention.
- Psychiatric: Can lead to mood swings, anxiety, and depression.
- Immune System: Increased susceptibility to infections.
- Skin Reactions: Acne, thinning skin, and easy bruising.
- Anti-inflammatory: Deflazacort works by inhibiting the production of inflammatory mediators like prostaglandins and leukotrienes.
- Immunosuppressive: It suppresses the immune system by inhibiting the activation of T-cells and other immune cells.
- Glucocorticoid Activity: Mimics the action of cortisol, a natural steroid hormone, to regulate metabolism and immune response.
- Gene Expression: Alters gene expression to reduce the synthesis of pro-inflammatory proteins.
- Cell Membrane Stability: Stabilizes cell membranes, reducing the release of inflammatory substances.
- Cytokine Inhibition: Inhibits the production of cytokines, which are involved in the inflammatory process.
- Lymphocyte Suppression: Reduces the number of circulating lymphocytes, thereby suppressing the immune response.
- NSAIDs: Increased risk of gastrointestinal bleeding when used with nonsteroidal anti-inflammatory drugs (NSAIDs).
- Anticoagulants: Deflazacort can enhance the effects of anticoagulants, increasing the risk of bleeding.
- Diuretics: Concurrent use with diuretics can lead to severe hypokalemia.
- Antidiabetic Drugs: May reduce the effectiveness of antidiabetic medications, requiring dose adjustments.
- Vaccines: Live vaccines should be avoided due to the risk of vaccine-induced infections.
- CYP3A4 Inhibitors: Drugs like ketoconazole can increase Deflazacort levels, leading to toxicity.
- CYP3A4 Inducers: Medications like rifampin can decrease Deflazacort levels, reducing its efficacy.
- Initial Dose: Typically 6 mg to 9 mg per day, depending on the condition being treated.
- Maintenance Dose: Once the condition is under control, the dose may be reduced to the lowest effective dose, often around 3 mg to 6 mg per day.
- Dosage Adjustment: Dose may need to be adjusted based on the patient's response and any side effects experienced.
- Tapering: Do not stop abruptly; the dose should be tapered gradually to avoid withdrawal symptoms.
- Administration: Usually taken once daily in the morning to mimic the body's natural cortisol rhythm.
- Monitoring: Regular monitoring of blood sugar, blood pressure, and bone density is recommended.
- Initial Dose: The initial dose for children is typically 0.9 mg/kg/day, not to exceed 36 mg/day.
- Maintenance Dose: Once the condition is controlled, the dose may be reduced to the lowest effective dose.
- Dosage Adjustment: Adjustments may be necessary based on the child's weight and response to treatment.
- Tapering: Gradual tapering is essential to avoid adrenal insufficiency.
- Monitoring: Regular monitoring of growth, blood sugar, and bone density is crucial in children.
- Administration: Administer once daily in the morning to align with the body's natural cortisol production.
- Dosage Adjustment: No specific dosage adjustment is generally required for patients with renal impairment.
- Monitoring: However, close monitoring of renal function is advised, especially in patients with severe renal impairment.
- Fluid Balance: Ensure proper fluid balance to avoid exacerbating renal issues.
- Electrolytes: Monitor electrolytes, particularly potassium, as Deflazacort can cause hypokalemia.
- Consultation: Always consult with a nephrologist if there are concerns about renal function.
Not available in a medicine form yet